-+ 0.00%
-+ 0.00%
-+ 0.00%

enGene Therapeutics announces annual shareholder meeting webcast

PUBT·05/08/2026 20:08:47
Listen to the news
enGene Therapeutics announces annual shareholder meeting webcast
  • enGene Therapeutics annual general meeting set for June 9, 2026, to be held virtually at www.virtualshareholdermeeting.com/ENGN2026.
  • Shareholders to vote on election of four directors for terms running to 2029, including Philip Astley-Sparke, Ronald H.W. Cooper, William Grossman, Michael Heffernan.
  • Ballot also includes appointment of KPMG as auditor for ensuing year, including authorization for board to set auditor remuneration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-020024), on May 08, 2026, and is solely responsible for the information contained therein.